# Opus Genetics, Inc.: filings

IRD · Nasdaq · CIK 1228627 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/ird.md) · [Financials](/companies/ird/financials.md) · [Filings](/companies/ird/filings.md) · [Insiders](/companies/ird/insiders.md)

## Reports and events: 307 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 307, 8-K 201, 10-Q 53, 3 30, 424B5 28, CORRESP 27, UPLOAD 25, DEFA14A 19, 10-K 18, DEF 14A 18, 144 14, S-8 13, SC 13G 13, SC 13G/A 13, ARS 10, EFFECT 10, SCHEDULE 13G/A 10, S-3 9, PRE 14A 8, 425 7, 5 7, S-3/A 6, SC 13D/A 6, SCHEDULE 13G 6, DFAN14A 5, 8-K/A 4, FWP 4, SEC STAFF LETTER 4, 10-K/A 3, 424B3 3, CT ORDER 3, S-4/A 3, SCHEDULE 13D/A 3, D 2, NT 10-Q 2, PREC14A 2, PRER14A 2, 25 1, 424B2 1, 424B4 1, 4/A 1, 8-A12B 1, CERT 1, DEFC14A 1, DEFR14A 1, PRRN14A 1, PX14A6G 1, S-4 1, SC 13D 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-21 | 16:05 ET | [8-K](/filings/0001140361-26-040377.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001140361-26-040377 |
| 2026-10-15 | 17:23 ET | [8-K](/filings/0001140361-26-039781.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-26-039781 |
| 2026-09-11 | 07:48 ET | [8-K](/filings/0001140361-26-036277.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-26-036277 |
| 2026-09-09 | 07:30 ET | [8-K](/filings/0001140361-26-035979.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-26-035979 |
| 2026-08-06 | 16:32 ET | [10-Q](/filings/0001628280-26-054381.md) | Quarterly report, period 2026-06-30 | 0001628280-26-054381 |
| 2026-08-06 | 07:04 ET | [8-K](/filings/0001628280-26-053824.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-053824 |
| 2026-06-16 | 16:11 ET | [8-K](/filings/0001140361-26-025440.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-26-025440 |
| 2026-06-16 | 12:05 ET | [8-K](/filings/0001140361-26-025363.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-26-025363 |
| 2026-05-20 | 19:53 ET | [SCHEDULE 13D/A](/filings/0001193125-26-233062.md) | Ownership report, active investor, amended | 0001193125-26-233062 |
| 2026-05-12 | 16:03 ET | [10-Q](/filings/0001628280-26-034084.md) | Quarterly report, period 2026-03-31 | 0001628280-26-034084 |
| 2026-05-12 | 07:01 ET | [8-K](/filings/0001628280-26-033856.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-033856 |
| 2026-04-24 | 17:08 ET | [8-K](/filings/0001140361-26-016764.md) | 2.03 New direct financial obligation | 0001140361-26-016764 |
| 2026-04-22 | 06:02 ET | [8-K](/filings/0001140361-26-015990.md) | 5.07 Shareholder vote results | 0001140361-26-015990 |
| 2026-04-07 | 07:01 ET | [8-K](/filings/0001140361-26-013481.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001140361-26-013481 |
| 2026-04-07 | 19:42 ET | [8-K](/filings/0001140361-26-013394.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-26-013394 |
| 2026-03-23 | 16:06 ET | [DEF 14A](/filings/0001140361-26-010757.md) | Proxy statement, period 2026-04-20 | 0001140361-26-010757 |
| 2026-03-12 | 16:52 ET | [10-K](/filings/0001140361-26-009247.md) | Annual report, period 2025-12-31 | 0001140361-26-009247 |
| 2026-03-10 | 07:17 ET | [8-K](/filings/0001140361-26-008621.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-26-008621 |
| 2026-02-19 | 16:02 ET | [8-K](/filings/0001140361-26-006176.md) | 1.01 Entry into a material agreement; 2.02 Results of operations; 3.02 Unregistered sale of equity; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-26-006176 |
| 2026-01-12 | 09:00 ET | [8-K](/filings/0001140361-26-000913.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-26-000913 |
| 2026-01-08 | 07:10 ET | [8-K](/filings/0001140361-26-000615.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-26-000615 |
| 2025-12-19 | 16:05 ET | [8-K](/filings/0001140361-25-046187.md) | 8.01 Other events | 0001140361-25-046187 |
| 2025-12-11 | 20:52 ET | [SCHEDULE 13D/A](/filings/0001193125-25-316569.md) | Ownership report, active investor, amended | 0001193125-25-316569 |
| 2025-11-12 | 07:23 ET | [10-Q](/filings/0001140361-25-041547.md) | Quarterly report, period 2025-09-30 | 0001140361-25-041547 |
| 2025-11-12 | 07:07 ET | [8-K](/filings/0001140361-25-041544.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-25-041544 |
| 2025-11-06 | 16:31 ET | [8-K](/filings/0001140361-25-040796.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-25-040796 |
| 2025-11-06 | 08:25 ET | [8-K](/filings/0001140361-25-040675.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-25-040675 |
| 2025-09-30 | 07:24 ET | [8-K](/filings/0001140361-25-036637.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-25-036637 |
| 2025-09-02 | 16:52 ET | [8-K](/filings/0001140361-25-033668.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-25-033668 |
| 2025-08-25 | 17:19 ET | [8-K](/filings/0001140361-25-032533.md) | 3.02 Unregistered sale of equity | 0001140361-25-032533 |
| 2025-08-13 | 16:47 ET | [10-Q](/filings/0001140361-25-030836.md) | Quarterly report, period 2025-06-30 | 0001140361-25-030836 |
| 2025-08-13 | 16:32 ET | [8-K](/filings/0001140361-25-030822.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-25-030822 |
| 2025-07-23 | 08:15 ET | [8-K](/filings/0001140361-25-026853.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-25-026853 |
| 2025-06-26 | 07:06 ET | [8-K](/filings/0001140361-25-023732.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-25-023732 |
| 2025-06-25 | 16:22 ET | [8-K](/filings/0001140361-25-023648.md) | 5.02 Departure or appointment of officers or directors | 0001140361-25-023648 |
| 2025-06-23 | 08:34 ET | [8-K](/filings/0001140361-25-023265.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-25-023265 |
| 2025-06-20 | 16:11 ET | [8-K](/filings/0001140361-25-023172.md) | 1.01 Entry into a material agreement | 0001140361-25-023172 |
| 2025-05-15 | 16:02 ET | [10-Q](/filings/0001140361-25-019266.md) | Quarterly report, period 2025-03-31 | 0001140361-25-019266 |
| 2025-05-15 | 08:27 ET | [8-K](/filings/0001140361-25-019153.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-25-019153 |
| 2025-05-06 | 17:55 ET | [SCHEDULE 13D/A](/filings/0000950170-25-064711.md) | Ownership report, active investor, amended | 0000950170-25-064711 |
| 2025-05-01 | 16:52 ET | [8-K](/filings/0001140361-25-016948.md) | 5.07 Shareholder vote results | 0001140361-25-016948 |
| 2025-04-04 | 16:39 ET | [8-K](/filings/0001140361-25-012366.md) | 1.02 Termination of a material agreement | 0001140361-25-012366 |
| 2025-03-31 | 17:14 ET | [10-K](/filings/0001140361-25-011410.md) | Annual report, period 2024-12-31 | 0001140361-25-011410 |
| 2025-03-31 | 08:26 ET | [8-K](/filings/0001140361-25-011181.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-25-011181 |
| 2025-03-24 | 17:27 ET | [8-K](/filings/0001140361-25-010064.md) | 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-25-010064 |
| 2025-03-20 | 17:27 ET | [8-K](/filings/0001140361-25-009729.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-25-009729 |
| 2025-03-20 | 09:21 ET | [8-K](/filings/0001999371-25-002866.md) | 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001999371-25-002866 |
| 2025-03-04 | 16:53 ET | [8-K](/filings/0001140361-25-006961.md) | 8.01 Other events | 0001140361-25-006961 |
| 2025-01-24 | 16:34 ET | [8-K](/filings/0001140361-25-001899.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001140361-25-001899 |
| 2025-01-23 | 17:20 ET | [8-K](/filings/0001140361-25-001819.md) | 8.01 Other events | 0001140361-25-001819 |

Page 1 of 7. [Older](/companies/ird/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 27, 2026, 16:48 ET. No prices; not investment advice.